Clinical Trial Detail

NCT ID NCT02244463
Title A Phase II Study of MLN0128 in Metastatic Anaplastic Thyroid Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements no
Sponsors Dana-Farber Cancer Institute
Indications

thyroid cancer

Therapies

Sapanisertib

Age Groups: adult

No variant requirements are available.